Baumer

Baumer Cost of Goods Sold

The Cost of Goods Sold (COGS) of Baumer (BALM4.SA) as of Nov 9, 2026 is 75.00 M BRL. In the previous year, Cost of Goods Sold (COGS) was 67.00 M BRL — a change of 11.94% (higher).

Cost of Goods Sold

75.00 MBRL

YoY

11.94%

Last updated:

Cost of Goods Sold (COGS) of Baumer is 2024 75.00 M BRL. Cost of Goods Sold (COGS) of Baumer was 2023 67.00 M BRL. It decreases by 11.94% higher compared to the previous year.

The Baumer Cost of Goods Sold history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cost of Goods Sold
Date
Cost of Goods Sold
Jan 1, 2017
46.28 M BRL
Jan 1, 2018
52.40 M BRL
Jan 1, 2019
72.02 M BRL
Jan 1, 2020
81.44 M BRL
Jan 1, 2021
58.66 M BRL
Jan 1, 2022
68.62 M BRL
Jan 1, 2023
67.00 M BRL
Jan 1, 2024
75.00 M BRL
The Baumer Cost of Goods Sold history
YEARCost of Goods SoldYoY
75.00 MBRL+11.94%
67.00 MBRL-2.36%
68.62 MBRL+16.98%
58.66 MBRL-27.97%
81.44 MBRL+13.07%
72.02 MBRL+37.45%
52.40 MBRL+13.21%
46.28 MBRL+7.49%
43.06 MBRL-2.33%
44.09 MBRL+3.05%
42.78 MBRL—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

Cost of Goods Sold (COGS) of Baumer is 75.00 M BRL in 2024.

Cost of Goods Sold (COGS) of Baumer changed from 67.00 M BRL to 75.00 M BRL, representing a 11.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cost of Goods Sold (COGS) Baumer since 2006 – with annual values, charts, and detailed analysis.

COGS represents the direct costs attributable to the production of goods sold. It includes material and labor costs directly tied to the product.

Cost of Goods Sold (COGS)'s BRL is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Cost of Goods Sold (COGS)'s Baumer historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Baumer

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Baumer